Another Massive Study Finds Measles Vaccine Doesn’t Cause Autism

| March 6, 2019

article image
A large-scale study of half a million people over 10 years confirms yet again that there is no connection between the measles, mumps, rubella (MMR) vaccine, and autism. No link has been found between the measles, mumps, rubella (MMR) vaccine, and autism in largest, single study to date. Researchers published their report on Monday in the journal Annals of Internal Medicine.

Spotlight

Leem

The Leem, the companies of the drug, brings together the companies of the sector of the pharmaceutical industry in France. Founded more than 130 years ago, Leem now has nearly 270 member companies, which account for nearly 98% of the total turnover of the drug in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees a year for the past 10 years.

OTHER ARTICLES

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | April 17, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Pharmacist eCare Plan - the newest disrupter in health data exchange?

Article | April 17, 2020

Every member of the health care team shares a common goal of optimizing patient outcomes. Yet each specialty and position of the healthcare team has a unique workflow facilitated by various tools, from an operative report to a progress note. In this regard the pharmacist plays a pivotal function in medication management and requires documentation specific to that role. The Pharmacist eCare Plan (PeCP) allows for an interoperable note to be used in the pharmacy to assist in the exchange of patient information, including active medication list, laboratory results, and payer information. To allow for this, a new type of clinical document architecture for the PeCP was created and standardized for use across pharmacies.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | April 17, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Spotlight

Leem

The Leem, the companies of the drug, brings together the companies of the sector of the pharmaceutical industry in France. Founded more than 130 years ago, Leem now has nearly 270 member companies, which account for nearly 98% of the total turnover of the drug in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees a year for the past 10 years.

Events